• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向不确定甲状腺病变的可靠诊断:基于高分辨魔角旋转核磁共振的代谢组学研究案例

Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of study.

作者信息

Torregrossa Liborio, Shintu Laetitia, Nambiath Chandran Jima, Tintaru Aura, Ugolini Clara, Magalhães Alviclér, Basolo Fulvio, Miccoli Paolo, Caldarelli Stefano

机构信息

Department of Surgery, University of Pisa , 56100 Pisa, Italy.

出版信息

J Proteome Res. 2012 Jun 1;11(6):3317-25. doi: 10.1021/pr300105e. Epub 2012 May 4.

DOI:10.1021/pr300105e
PMID:22509853
Abstract

Cytological analysis of thyroid nodules detected using ultrasound-guided fine-needle aspiration technique is an efficient method for the diagnosis of well-differenciated tumors such as papillary thyroid carcinoma. However, for between 10 to 30% of all the nodules, the cytological analysis based on fine-needle aspiration biopsies leads to an "indeterminated" identification. Consequently, a surgical excision is then necessary for a definite histological diagnosis of the lesions, resulting in 85% of the patient with indeterminated nodules undergoing unnecessary surgery since their tumor is finally diagnosed as benign. In this work, we discuss how HRMAS (1)H NMR-based metabolomics could be a complementary tool for the diagnosis of these elusive cases. We first showed that our approach was able to discriminate clearly any types of thyroid lesions from healthy tissues. Then we proceeded to demonstrate that the information produced by (1)H HRMAS NMR spectra differentiate tumors according to their malignancy grade, even when they belong to the "indeterminate" category. Analysis of the discriminating spectral area in this last case points out toward a possible increase of phenylalanine, taurine, and lactate and a decrease of choline and choline derivatives, myo- and scyllo-inositol in the malignant tumors compared to the benign ones.

摘要

使用超声引导下细针穿刺技术检测甲状腺结节的细胞学分析是诊断如甲状腺乳头状癌等高分化肿瘤的有效方法。然而,在所有结节中,有10%至30%的结节基于细针穿刺活检的细胞学分析会得出“不确定”的结果。因此,为了对病变进行明确的组织学诊断,需要进行手术切除,这导致85%的不确定结节患者接受了不必要的手术,因为他们的肿瘤最终被诊断为良性。在这项工作中,我们讨论了基于高分辨魔角旋转氢核磁共振波谱(HRMAS 1H NMR)的代谢组学如何能够成为诊断这些疑难病例的补充工具。我们首先表明,我们的方法能够清晰地区分任何类型的甲状腺病变与健康组织。然后我们进一步证明,即使肿瘤属于“不确定”类别,1H HRMAS NMR谱产生的信息也能根据肿瘤的恶性程度对其进行区分。对最后这种情况下的鉴别谱区分析指出,与良性肿瘤相比,恶性肿瘤中苯丙氨酸、牛磺酸和乳酸可能增加,胆碱及其衍生物、肌醇和鲨肌醇减少。

相似文献

1
Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of study.迈向不确定甲状腺病变的可靠诊断:基于高分辨魔角旋转核磁共振的代谢组学研究案例
J Proteome Res. 2012 Jun 1;11(6):3317-25. doi: 10.1021/pr300105e. Epub 2012 May 4.
2
Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics.采用基于高分辨魔角旋转核磁共振波谱的代谢组学技术诊断甲状腺病变术后细针穿刺抽吸活检中细胞学不确定的病例。
Metabolomics. 2018 Oct 10;14(10):141. doi: 10.1007/s11306-018-1437-6.
3
Metabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based study.基于高分辨魔角旋转核磁共振的甲状腺结节代谢组学研究。
Surgery. 2012 Dec;152(6):1118-24. doi: 10.1016/j.surg.2012.08.037.
4
Follicular lesions of the thyroid.甲状腺滤泡性病变
Surg Clin North Am. 2014 Jun;94(3):499-513. doi: 10.1016/j.suc.2014.02.005. Epub 2014 Apr 3.
5
Evaluation of the role of magnetic resonance spectroscopy in the diagnosis of follicular malignancies of thyroid.
Arch Surg. 2011 Feb;146(2):179-82. doi: 10.1001/archsurg.2010.345.
6
Proton magnetic resonance and human thyroid neoplasia. II: Potential avoidance of surgery for benign follicular neoplasms.质子磁共振与人类甲状腺肿瘤。II:良性滤泡性肿瘤潜在的手术避免
World J Surg. 1994 Jul-Aug;18(4):512-6; discussion 516-7. doi: 10.1007/BF00353751.
7
Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.甲状腺细针穿刺活检中滤泡性病变与滤泡性肿瘤的临床意义。
Ann Surg Oncol. 2009 Nov;16(11):3146-53. doi: 10.1245/s10434-009-0666-3.
8
Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropin.甲状腺滤泡性肿瘤的恶性风险:促甲状腺激素的预测价值
Nuklearmedizin. 2012;51(4):119-24. doi: 10.3413/Nukmed-0456-12-01. Epub 2012 Apr 12.
9
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.高迁移率族蛋白I HMGI(Y)在甲状腺肿瘤诊断中的检测:HMGI(Y)表达是癌的一种潜在诊断指标。
Cancer Res. 1998 Sep 15;58(18):4193-8.
10
Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.甲状腺肿瘤的分子表型分析确定了用于分化型甲状腺癌诊断的标志物组合。
Ann Surg Oncol. 2008 Oct;15(10):2811-26. doi: 10.1245/s10434-008-0034-8. Epub 2008 Jul 9.

引用本文的文献

1
Single-cell RNA sequencing and multi-omics analysis of prognosis-related staging in papillary thyroid cancer.甲状腺乳头状癌预后相关分期的单细胞RNA测序和多组学分析
Cancer Immunol Immunother. 2025 Jul 12;74(8):267. doi: 10.1007/s00262-025-04101-4.
2
Emerging Potential of Metabolomics in Thyroid Cancer-A Comprehensive Review.代谢组学在甲状腺癌中的新兴潜力——综述
Cancers (Basel). 2025 Mar 18;17(6):1017. doi: 10.3390/cancers17061017.
3
Exploring the potential of myo-inositol in thyroid disease management: focus on thyroid cancer diagnosis and therapy.
探讨肌醇在甲状腺疾病管理中的潜力:聚焦甲状腺癌的诊断与治疗。
Front Endocrinol (Lausanne). 2024 Sep 12;15:1418956. doi: 10.3389/fendo.2024.1418956. eCollection 2024.
4
The Role of Inositols in Endocrine and Neuroendocrine Tumors.肌醇在内分泌和神经内分泌肿瘤中的作用。
Biomolecules. 2024 Aug 14;14(8):1004. doi: 10.3390/biom14081004.
5
Metabolite signature of human malignant thyroid tissue: A systematic review and meta-analysis.人类恶性甲状腺组织的代谢物特征:系统评价和荟萃分析。
Cancer Med. 2024 Apr;13(8):e7184. doi: 10.1002/cam4.7184.
6
Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine.使用血浆三甲胺 N-氧化物、肉碱、胆碱和甜菜碱鉴别甲状腺良恶性结节。
J Cancer Res Clin Oncol. 2024 Mar 20;150(3):142. doi: 10.1007/s00432-024-05666-w.
7
Experimental study on changes in metabolic mechanism of papillary thyroid carcinoma complicated with Hashimoto's thyroiditis.甲状腺乳头状癌合并桥本甲状腺炎代谢机制变化的实验研究
Heliyon. 2023 Oct 5;9(10):e20661. doi: 10.1016/j.heliyon.2023.e20661. eCollection 2023 Oct.
8
Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto's thyroiditis.伴有和不伴有桥本甲状腺炎的甲状腺乳头癌患者氨基酸谱的变化。
Front Endocrinol (Lausanne). 2023 Aug 18;14:1199291. doi: 10.3389/fendo.2023.1199291. eCollection 2023.
9
Pilot Study on the Use of Untargeted Metabolomic Fingerprinting of Liquid-Cytology Fluids as a Diagnostic Tool of Malignancy for Thyroid Nodules.利用液体细胞学液的非靶向代谢组学指纹图谱作为甲状腺结节恶性肿瘤诊断工具的初步研究。
Metabolites. 2023 Jun 23;13(7):782. doi: 10.3390/metabo13070782.
10
Metabolomics-A Tool to Find Metabolism of Endocrine Cancer.代谢组学——寻找内分泌癌代谢情况的工具。
Metabolites. 2022 Nov 21;12(11):1154. doi: 10.3390/metabo12111154.